U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630558) titled 'Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer' on May 28.
Brief Summary: This study retrospectively analyze tumor samples and clinical data from Greek women with operable breast cancer of intermediate or high-risk of relapse who participated in HeCOG adjuvant studies. Patients were treated with dose-dense sequential adjuvant chemotherapy regimens mainly including epirubicin, cyclophosphamide, taxanes, and "intensified" CMF.
The main goal is to investigate how tumor characteristics and genetic mutations relate to breast cancer subtype and p...